Melanie BlokeschMelanie Blokesch holds a PhD degree from the Ludwig-Maximilians-Universität in Munich, Germany. After a postdoctoral stay at Stanford University (USA; Department of Microbiology and Immunology) she joined EPFL as a tenure-track Assistant Professor in 2009 and was promoted to Associate Professor (tenured) in 2016. In 2018, Melanie Blokesch was nominated as new member of the the Swiss National Science Foundation (SNSF) National Research Council (starting date: April 2019). Melanie Blokesch is also an elected member of the European Academy of Microbiology (EAM; since 2018) and the European Molecular Biology Organization (EMBO; since 2019). Among other awards and grants, Melanie Blokesch has been honored with the Prize for Junior Scientists of the German National Academy of Sciences Leopoldina in 2005, an ERC Starting Grant in 2012, the EPFL teaching award "Polysphère" for best teacher in the School of Life Sciences (academic year 2014-2015), the Research Award by the Association for General and Applied Microbiology (VAAM; Germany) in 2015, and an ERC Consolidator Grant in 2016. In 2017, Melanie Blokesch was awarded a Howard Hughes Medical Institute (HHMI) International Research Scholarship.
Jacques-Edouard MoserJacques-Edouard Moser is titular professor in physical chemistry and is currently directing the Group for Photochemical Dynamics (Moser Group) of EPFL. He is a graduate of the École polytechnique fédérale de Lausanne, where he received a diploma degree (MSc) in chemical engineering in 1982. After two stays in 1984 and 1985 at Concordia University in Montréal (Canada), he earned in 1986 his Ph.D. in physical chemistry at EPFL (Michael Grätzel, thesis advisor). In 1986, he joined the Eastman Kodak Corporate Research Laboratories at Rochester (NY, USA) as a postdoctoral fellow and was later associated with the NSF Center for Photoinduced Electron Transfer at the University of Rochester. Returning to Switzerland, he was appointed as a lecturer of physical chemistry at EPFL in 1992 and was awarded the habilitation and the venia legendi in 1998. He is titular professor since 2005.His research activity focuses on the study of the dynamics of photoinduced electron transfer and charge carrier separation at donor-acceptor heterojunctions and in nanostructured semiconductors. He is the author and co-author of ca 200 scientific papers (H-index 75). He currently teaches general physical chemistry to freshmen students in chemistry. He gives two classes on general- and redox photochemistry in the MSc program in chemistry and chemical engineering and the doctoral programs in energy and photonics.
Jacques-E. Moser presided the Swiss Society of Photochemistry and Photophysics (1995-1998) and chaired the jury of the Grammaticakis-Neumann international prize in photochemistry (1999-2001). He was a member of the board of the Swiss Chemical Society (2007-2012). He served as a member of the standing committee of the European Photochemistry Association (1992-2000) and of the executive committee of the division for fundamental research of the Swiss Chemical Society (1999-2014). He was the director of the Section of Chemistry and Chemical Engineering of EPFL and a member of the direction of the School of Basic Sciences from 2007 to 2015.
Françoise Gisou van der Goot GrunbergGisou van der Goot is the Head of the Laboratory of Cell and Membrane Biology, and founding member of the Global Health Institute (GHI), School of Life Sciences, at the Swiss Federal Institute of Technology Lausanne/EPFL (Ecole Polytechnique Fédérale de Lausanne). She is currently Vice President for Responsible Transformation, in charge of reinforcing values such as inclusion and sustainability throughout the School’s campus. From 2014 to 2020, she was Dean of the School of Life Sciences. Before joining EPFL, she was Group Leader at the Faculty of Sciences of the University of Geneva (UNIGE) and subsequently Associate Professor at the Faculty of Medicine of the same university. She studied engineering at the Ecole Centrale de Paris, then did a PhD in Molecular Biophysics at the Nuclear Energy Research Center, Saclay, France, followed by a postdoc at the European Molecular Biology Laboratory (EMBL) in Heidelberg. She obtained an EMBO Young Investigator award in 2001, a Howard Hughes International Scholar award in 2005 and the Swiss Prix Marcel Benoist in 2009, the same year she was elected EMBO member (European Molecular Biology Organisation). She is a leader in the fields of molecular and cellular understanding of bacterial toxins, the organization of mammalian membranes and in organelles biology. Professor van der Goot is member of diverse scientific boards such as the Swiss National Science Foundation (SNF), the Conseil suisse de la science et de la technologie (CSST) and the European Research Council (ERC).
Johan AuwerxJohan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways.
Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards.
Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.
